Objective: To compare effects of melatonin with that of nonsteroidal anti-inflammatory drugs (NSAIDs) and behavioral therapy on patients sustaining myofascial pain. Material and Methods: A total of 45 patients were included and assigned into 3 groups; a melatonin (6 mg) group, a NSAID group and a behavioral treatment group. Preoperative, first- and third-month clinical parameters (masticatory muscle pain, temporomandibular joint region pain, facial pain, amount of mouth opening) were assessed using Research Diagnostic Criteria for Temporomandibular Disorders form retrospectively. Besides, sleep quality was assessed using Visual Analog Sleep Quality Scale at the same periods. Results: Following assessment of records of 300 (224 females and 76 males) patients 45 of them who met the inclusion criteria were included in the study. In the first month, facial pain decreased significantly in the melatonin group compared to other two groups (p1: 0.011; p2: 0.044). Mouth opening did not differ between the NSAID and the melatonin group (p>0.05), but was significantly lower in the behavioral treatment group (p1: 0.000; p2: 0.004; p<0.05). Considering muscle and temporomandibular joint pain, the melatonin group showed the least pain level. In the first and third months, sleep quality scores was did not show significant difference between the treatment groups (p>0.05), but increased significantly higher in the melatonin group compared to other two groups (p: 0.000; p<0.05). Conclusion: Complaints subsided in all the treatment groups. Melatonin can be considered as an agent that has analgesic and anti-inflammatory effects in myofascial pain. Further studies in this field are necessary those evaluate different regimens and routes of melatonin use.
Keywords: Temporomandibular joint; temporomandibular disorders; facial pain; melatonin
Amaç: Miyofasiyal ağrılı hastalarda melatoninin etkilerinin nonsteroid antiinflamatuar (NSAİİ) ilaçlarla ve davranışsal terapiyle karşılaştırılmasıdır. Gereç ve Yöntemler: Bu çalışma için toplam 45 hasta; melatonin (6 mg) grubu, NSAİİ grubu ve davranışsal terapi grubu olmak üzere 3 gruba ayrıldı. Temporomandibular Rahatsızlıklar için raştırma Teşhis Kriterleri formu kullanılarak preoperatif ve 1. ay, 3. ay klinik parametreleri (çiğneme kaslarında ağrı, temporomandibular eklem bölgesinde ağrı, yüz ağrısı, ağız açıklığı miktarı) retrospektif olarak değerlendirildi. Ayrıca, aynı periyotlarda uyku kalitesi Görsel Analog Uyku Kalite Skalası kullanılarak değerlendirildi. Bulgular: Bu çalışma için 300 (224 kadın, 76 erkek) hastanın değerlendirilmesi sonucu 45 hastanın dâhil edilmesine karar verildi. Birinci ayda melatonin grubunda fasiyal ağrı diğer 2 gruba göre anlamlı derecede azaldı (p1: 0,011; p2: 0,044). Ağız açıklığı miktarı, NSAİİ ve melatonin gruplarında farklı değilken (p>0,05), davranışsal terapi grubunda anlamlı derece azalmıştı (p1: 0,000; p2: 0,004; p<0,05). Çiğneme kasları ve temporomandibular eklem ağrısı açısından, en az ağrı seviyesi melatonin grubunda görüldü. Birinci ve 3. aylarda, uyku kalitesi gruplar arasında farklı bulunmadı (p>0,05), ancak; melatonin grubunda uyku kalitesindeki artış diğer 2 gruptan daha fazlaydı (p: 0,000; p<0,05). Sonuç: Bütün gruplarda hasta şikâyetlerinin azaldığı görüldü. Melatonin, analjezik ve antiinflamatuar etkileriyle miyofasiyal ağrıda kullanılabilecek bir ajan olarak düşünülebilir. Bu alanda melatonin farklı dozlarına ve uygulama şekillerine göre ileri çalışmalara ihtiyaç vardır.
Anahtar Kelimeler: Temporomandibular eklem; temporomandibular düzensizlikler; fasiyal ağrı; melatonin
- de Leeuw R, Klasser GD. American academy of orofacial pain. Orofacial Pain: Guidelines for Assessment, Diagnosis and Management. 6th ed. Hanover Park, Chicago: IL Quintessence; 2018. p.144-207.
- Gerwin RD. Diagnosis of myofascial pain syndrome. Phys Med Rehabil Clin N Am. 2014;25(2):341-55. [Crossref] [PubMed]
- Urits I, Charipova K, Gress K, Schaaf AL, Gupta S, Kiernan HC, et al. Treatment and management of myofascial pain syndrome. Best Pract Res Clin Anaesthesiol. 2020;34(3):427-48. [Crossref] [PubMed]
- Pooja S, Pradeep S. Advances in the management of myofascial pain dysfunction syndrome-A short review. Drug Invention Today. 2019;12(2):309-13. [Link]
- Nagpal A, Bickelhaupt B. 32 myofascial pain. Ramamurthy's Decision Making in Pain Management. 3rd ed. New Delhi, India: Jaypee Brothers Medical Publishers; 2018. p.89-91.
- Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc. 2017;83:h7. [PubMed]
- Smith MT, Wickwire EM, Grace EG, Edwards RR, Buenaver LF, Peterson S, et al. Sleep disorders and their association with laboratory pain sensitivity in temporomandibular joint disorder. Sleep. 2009;32(6):779-90. [Crossref] [PubMed] [PMC]
- Dubrovsky B, Raphael KG, Lavigne GJ, Janal MN, Sirois DA, Wigren PE, et al. Polysomnographic investigation of sleep and respiratory parameters in women with temporomandibular pain disorders. J Clin Sleep Med. 2014;10(2):195-201. [Crossref] [PubMed] [PMC]
- Onen SH, Alloui A, Gross A, Eschallier A, Dubray C. The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res. 2001;10(1):35-42. [Crossref] [PubMed]
- Oh SN, Myung SK, Jho HJ. Analgesic efficacy of melatonin: a meta-analysis of randomized. double-blind, placebo-controlled trials. Journal of Clinical Medicine. 2020;9(5):1553. [Crossref] [PubMed] [PMC]
- Liu S; Madu CO, Lu Y. The role of melatonin in cancer development. Oncomedicine. 2018;3:37-47. [Crossref]
- Ambriz-Tututi M, Rocha-González HI, Cruz SL, Granados-Soto V. Melatonin: a hormone that modulates pain. Life Sci. 2009;84(15-16):489-98. [Crossref] [PubMed]
- Chen WW, Zhang X, Huang WJ. Pain control by melatonin: physiological and pharmacological effects. Exp Ther Med. 2016;12(4):1963-8. [Crossref] [PubMed] [PMC]
- Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord. 1992;6(4):301-55. [PubMed]
- Jyothi S, Dhanraj M. Non-surgical treatment for tempromandibular joint disorder-a review. Research J Pharm and Tech. 2017;10(3):917. [Crossref]
- Tantanatip A, Chang KV. Myofascial Pain Syndrome. 2022 Jul 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. [PubMed]
- McNeill C. Management of temporomandibular disorders: concepts and controversies. J Prosthet Dent. 1997;77(5):510-22. [Crossref] [PubMed]
- Sengupta P, Chakraborty S, Ray A. Non-invasive management of temporomandibular joint disorders: review of literatures. J Med Dent Sci Res. 2022;9(3):82-93. [Link]
- Aktas I, Yalcin S, Sencer S. Intra-articular injection of tenoxicam following temporomandibular joint arthrocentesis: a pilot study. Int J Oral Maxillofac Surg. 2010;39(5):440-5. [Crossref] [PubMed]
- Brune K, Patrignani P. New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Res. 2015;8:105-18. [Crossref] [PubMed] [PMC]
- Dolin SJ, Cashman JN, Bland JM. Effectiveness of acute postoperative pain management: I. Evidence from published data. Br J Anaesth. 2002;89(3):409-23. [Crossref] [PubMed]
- Peres MF, Zukerman E, da Cunha Tanuri F, Moreira FR, Cipolla-Neto J. Melatonin, 3 mg, is effective for migraine prevention. Neurology. 2004;63(4):757. [Crossref] [PubMed]
- El-Shenawy SM, Abdel-Salam OM, Baiuomy AR, El-Batran S, Arbid MS. Studies on the anti-inflammatory and anti-nociceptive effects of melatonin in the rat. Pharmacol Res. 2002;46(3):235-43. [Crossref] [PubMed]
- Scarabelot VL, Medeiros LF, de Oliveira C, Adachi LN, de Macedo IC, Cioato SG, et al. Melatonin alters the mechanical and thermal hyperalgesia induced by orofacial pain model in rats. Inflammation. 2016;39(5):1649-59. [Crossref] [PubMed]
- Danilov A, Kurganova J. Melatonin in chronic pain syndromes. Pain Ther. 2016;5(1):1-17. [Crossref] [PubMed] [PMC]
- Wilhelmsen M, Amirian I, Reiter RJ, Rosenberg J, Gögenur I. Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. J Pineal Res. 2011;51(3):270-7. [Crossref] [PubMed]
- Citera G, Arias MA, Maldonado-Cocco JA, Lázaro MA, Rosemffet MG, Brusco LI, et al. The effect of melatonin in patients with fibromyalgia: a pilot study. Clin Rheumatol. 2000;19(1):9-13. [Crossref] [PubMed]
- de Zanette SA, Vercelino R, Laste G, Rozisky JR, Schwertner A, Machado CB, et al. Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial. BMC Pharmacol Toxicol. 2014;15:40. [Crossref] [PubMed] [PMC]
- Vidor LP, Torres IL, Custódio de Souza IC, Fregni F, Caumo W. Analgesic and sedative effects of melatonin in temporomandibular disorders: a double-blind, randomized, parallel-group, placebo-controlled study. J Pain Symptom Manage. 2013;46(3):422-32. [Crossref] [PubMed]
- Andersen LP. The analgesic effects of exogenous melatonin in humans. Dan Med J. 2016;63(10):B5289. [PubMed]
- Andersen LP, Gögenur I, Rosenberg J, Reiter RJ. The safety of melatonin in humans. Clin Drug Investig. 2016;36(3):169-75. [Crossref] [PubMed]
- Hansen MV, Andersen LT, Madsen MT, Hageman I, Rasmussen LS, Bokmand S, et al. Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial. Breast Cancer Res Treat. 2014;145(3):683-95. [Crossref] [PubMed]
- de Matos Cavalcante AG, de Bruin PF, de Bruin VM, Nunes DM, Pereira ED, Cavalcante MM, et al. Melatonin reduces lung oxidative stress in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study. J Pineal Res. 2012;53(3):238-44. [Crossref] [PubMed]
- Lobbezoo F, Van Der Zaag J, Naeije M. Bruxism: its multiple causes and its effects on dental implants - an updated review. J Oral Rehabil. 2006;33(4):293-300. [Crossref] [PubMed]
- Serra-Negra JM, Scarpelli AC, Tirsa-Costa D, Guimarães FH, Pordeus IA, Paiva SM. Sleep bruxism, awake bruxism and sleep quality among Brazilian dental students: a cross-sectional study. Braz Dent J. 2014;25(3):241-7. [Crossref] [PubMed]
.: Process List